SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-024882
Filing Date
2014-04-01
Accepted
2014-04-01 16:30:30
Documents
7
Period of Report
2014-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-9393_18k.htm 8-K 25317
2 EX-10.1 a14-9393_1ex10d1.htm EX-10.1 554327
3 GRAPHIC g93931kg09i001.gif GRAPHIC 18558
4 GRAPHIC g93931kg17i001.gif GRAPHIC 112639
5 GRAPHIC g93931kg17i002.gif GRAPHIC 170128
6 GRAPHIC g93931kg17i003.gif GRAPHIC 131088
7 GRAPHIC g93931kg17i004.gif GRAPHIC 133472
  Complete submission text file 0001104659-14-024882.txt   1361141
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 14734612
SIC: 2834 Pharmaceutical Preparations